New targets for PPARgamma in the vessel wall: implications for restenosis.
about
The NR4A orphan nuclear receptor NOR1 is induced by platelet-derived growth factor and mediates vascular smooth muscle cell proliferationEffect of PPARgamma inhibition on pulmonary endothelial cell gene expression: gene profiling in pulmonary hypertension.Endothelial and vascular muscle PPARgamma in arterial pressure regulation: lessons from genetic interference and deficiency.Peroxisome proliferator-activated receptors, metabolic syndrome and cardiovascular disease.Distinct roles of E2F proteins in vascular smooth muscle cell proliferation and intimal hyperplasia.Identification and characterization of [6]-shogaol from ginger as inhibitor of vascular smooth muscle cell proliferation.Treatment update: thiazolidinediones in combination with metformin for the treatment of type 2 diabetes.PPARalpha and PPARgamma effectively protect against HIV-induced inflammatory responses in brain endothelial cellsPeroxisome proliferator-activated receptor γ agonist suppresses human telomerase reverse transcriptase expression and aromatase activity in eutopic endometrial stromal cells from endometriosisPioglitazone abrogates cyclosporine-evoked hypertension via rectifying abnormalities in vascular endothelial function.Molecular basis for impaired collateral artery growth in the spontaneously hypertensive rat: insight from microarray analysisFenretinide inhibits macrophage inflammatory mediators and controls hypertension in spontaneously hypertensive rats via the peroxisome proliferator-activated receptor gamma pathway.Peroxisome proliferator-activated receptors and atherosclerosis.Peroxisome proliferator-activated receptor-γ and the endothelium: implications in cardiovascular disease.PPARgamma and Agonists against Cancer: Rational Design of Complementation Treatments.
P2860
Q24677863-0658B1F8-776E-4F5F-8BD7-E327A565A60CQ33593476-A9F8CF87-6710-42D1-8A74-18A188846458Q33642053-EAE1C880-924A-4993-8083-0FB5A41CBD2DQ35636191-EF7B998B-936C-4F79-B403-69D0BA28FE60Q35928855-768F3312-A027-4094-82E7-3C9AF303CEAFQ36069458-0B87E0BF-AD9B-4766-B4D3-112463FD205BQ36536290-F4F2060A-35C7-4F5A-8E6F-A91BA85AA0AEQ37002797-FD2C9A27-6C8B-4C78-B901-8FDD3A337711Q37022398-D271B1EF-620B-4951-AAE2-C9496A56EAE4Q37183438-1957886E-C52A-44AF-8400-2AAF02681736Q37319355-765363CC-B1ED-4C6C-A507-8DE30E4B27CBQ37397863-9E85C06A-868E-4FAA-A284-8E6AD6AB7011Q37861955-9B6D93F9-4574-47A5-BB89-AA49ABBA992DQ37943863-2967F0CC-780C-4E3C-B8BA-30D4638248E2Q41677812-F3CE8EEA-D952-48EC-B2A3-427739D5FC00
P2860
New targets for PPARgamma in the vessel wall: implications for restenosis.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
New targets for PPARgamma in the vessel wall: implications for restenosis.
@ast
New targets for PPARgamma in the vessel wall: implications for restenosis.
@en
type
label
New targets for PPARgamma in the vessel wall: implications for restenosis.
@ast
New targets for PPARgamma in the vessel wall: implications for restenosis.
@en
prefLabel
New targets for PPARgamma in the vessel wall: implications for restenosis.
@ast
New targets for PPARgamma in the vessel wall: implications for restenosis.
@en
P2093
P2860
P356
P1476
New targets for PPARgamma in the vessel wall: implications for restenosis.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.IJO.0802910
P407
P478
29 Suppl 1
P577
2005-03-01T00:00:00Z